classic
immunoglobin
g
igg
wide
use
mani
biotechnolog
therapeut
igg
best
describ
heterodimer
homodim
consist
two
copi
disulfidebond
heavi
h
light
l
chain
h
l
chain
variabl
v
domain
vh
vl
respect
combin
form
antigenbind
region
two
v
domain
synthes
dualdomain
singlechain
v
fragment
scfv
minimum
size
fragment
kda
recent
year
singledomain
immunoglobulin
shark
vnar
new
antigen
receptor
variabl
domain
camelid
heavychain
variabl
domain
vhh
antibodi
explor
isol
solubl
stabl
monomer
bind
domain
vnar
vhh
domain
antibodi
rang
kda
size
roughli
half
size
scfv
bind
domain
cartilagin
fish
shark
ray
skate
chimaera
phylogenet
oldest
live
organ
use
antibodi
part
adapt
immun
system
produc
three
differ
antibodi
isotyp
function
humor
immun
respons
immunoglobulin
igm
immunoglobulin
w
igw
immunoglobulin
new
antigen
receptor
ignar
ignar
antibodi
homodimer
protein
compos
heavi
chain
antigenbind
region
end
chain
serv
major
compon
humor
respons
number
camelid
vhh
domain
evalu
phase
ii
iii
clinic
trial
even
though
shark
vnar
less
known
potenti
use
biolog
therapeut
base
small
size
abil
penetr
dens
tissu
inaccess
igg
ii
abil
bind
protein
cleft
buri
function
site
eg
enzym
pocket
site
substrat
iii
solubl
robust
harsh
condit
iv
abil
highaffin
includ
subnanomolar
bind
addit
antibodi
potenti
bind
wide
rang
antigen
despit
natur
singledomain
architectur
vnar
domain
ig
superfamili
domain
two
sheet
held
togeth
two
canon
cystein
residu
framework
region
fr
addit
canon
cystein
complementar
determin
region
one
two
addit
cystein
form
addit
disulfid
bond
within
v
domain
ignar
classifi
four
type
base
number
posit
noncanon
cystein
vnar
domain
type
vnar
contain
two
noncanon
cystein
residu
encod
divers
region
nnucleotid
addit
form
two
disulfid
bond
interestingli
type
report
nurs
shark
ginglymostoma
cirratum
type
ii
vnar
domain
form
disulfid
bond
one
dencod
noncanon
cystein
anoth
noncanon
cystein
type
iii
similar
type
ii
except
highli
conserv
tryptophan
residu
posit
adjac
disulfid
bond
type
iv
noncanon
disulfid
bond
found
three
vnar
type
type
type
ii
vnar
protrud
enabl
bind
pocket
groov
classic
igg
camelid
vhh
contain
loop
present
shark
vnar
replac
highli
divers
amino
acid
term
hypervari
region
addit
second
hypervari
region
name
insert
middl
therefor
separ
shark
vnar
domain
may
advantag
properti
convent
igg
first
shark
evolutionarili
distant
mammal
phylogenet
tree
therefor
gener
highaffin
binder
structur
conserv
mammalian
drug
target
may
includ
highli
conserv
heparan
sulfat
proteoglycan
gprotein
coupl
receptor
ion
channel
may
exhibit
poor
immunogen
mice
rabbit
second
elong
shark
camel
antibodi
abil
seek
buri
epitop
enzym
function
site
shark
ignar
region
rel
longer
rang
aa
includ
variou
number
cystein
residu
compar
mous
human
counterpart
potenti
lead
larger
divers
structur
interact
diversifi
antigen
similarli
longer
region
shark
antibodi
possess
extraordinari
capac
form
long
fingerlik
extens
probe
protein
hidden
epitop
third
convent
antibodi
may
poor
tissu
penetr
abil
due
larg
size
whole
igg
kda
scfv
fragment
kda
vnar
domain
small
kda
final
shark
vnar
domain
antibodi
structur
advantag
easili
express
escherichia
coli
system
shark
enrich
blood
urea
maintain
osmot
balanc
marin
environ
shark
antibodi
structur
evolv
becom
particularli
stabl
phage
display
technolog
use
isol
shark
vnar
antibodi
one
studi
two
shark
vnar
librari
size
clone
construct
spini
dogfish
squalu
acanthia
smooth
dogfish
mustelu
cani
shark
phage
antibodi
isol
immun
shark
specif
antigen
hen
egg
white
lysozym
synthet
shark
vnar
singledomain
librari
also
pursu
howev
none
approach
gener
larg
shark
vnar
singledomain
librari
cover
wide
rang
divers
requir
commonli
therapeut
antibodi
discoveri
studi
develop
pcrextens
assembl
selfligationbas
method
name
easel
make
larg
phagedisplay
vnar
singledomain
librari
six
nurs
shark
nurs
shark
chosen
maxim
divers
vnar
librari
exclus
report
contain
type
vnar
domain
assess
divers
analyz
vnar
sequenc
largest
scale
field
conduct
nextgener
sequenc
ng
analysi
million
uniqu
fulllength
vnar
uniqu
sequenc
analyz
use
unbias
method
investig
cystein
number
length
vnar
sequenc
togeth
well
type
type
iiiii
vnar
separ
valid
potenti
librari
new
platform
therapeut
antibodi
discoveri
conduct
phage
pan
identifi
shark
vnar
binder
panel
tumor
viral
antigen
includ
antigen
associ
liver
breast
cancer
well
antigen
viral
protein
associ
sar
mer
select
binder
includ
type
ii
vnar
produc
success
e
coli
solubl
protein
antigenbind
valid
work
valid
larg
divers
nurs
shark
vnar
librari
util
shark
vnar
librari
platform
therapeut
antibodi
discoveri
construct
larg
shark
vnar
librari
develop
method
call
easel
illustr
figur
isol
peripher
blood
leukocyt
six
adult
nurs
shark
g
cirratum
amplifi
shark
vnar
sequenc
pcr
primer
revers
primer
contain
sequenc
backbon
extens
overlap
pcr
conduct
combin
vnar
phagemid
backbon
fig
final
gel
purif
perform
selflig
ligas
circular
assembl
vnar
plasmid
shark
vnar
librari
size
determin
titrat
base
number
individu
bacteria
coloni
agar
plate
higheffici
method
signific
improv
convent
phage
librari
construct
method
usual
requir
mani
round
restrict
enzym
digest
ligat
make
previou
method
labor
intens
time
consum
moreov
sequenc
divers
shark
vnar
preserv
repres
method
maximum
degre
due
highli
effici
pcrbase
amplif
ligat
analyz
divers
librari
perform
deep
sequenc
whole
librari
use
ng
sequenc
done
twice
forward
revers
direct
pairedend
read
merg
pairedend
read
perform
high
stringenc
combin
forward
revers
sequenc
result
ensur
accuraci
uniqu
sequenc
nearli
million
fulllength
vnar
sequenc
infram
translat
use
analysi
focu
cystein
number
length
amino
acid
variabl
vnar
type
count
largest
scale
shark
vnar
sequenc
analysi
report
thu
far
shown
figur
presenc
two
canon
cystein
locat
amino
acid
use
key
criterion
character
type
vnar
sequenc
contain
one
cystein
consid
type
n
total
vnar
fit
four
known
vnar
type
famili
sequenc
n
categor
base
placement
addit
cystein
type
iv
vnar
contain
two
canon
cystein
found
posit
n
type
vnar
contain
extra
cystein
posit
n
total
vnar
group
divid
subtyp
base
mani
addit
cystein
contain
classic
definit
type
vnar
describ
antibodi
total
six
cystein
total
vnar
classic
type
type
ii
iii
vnar
least
one
extra
cystein
amino
acid
n
total
vnar
among
total
vnar
classic
type
ii
uniqu
fulllength
vnar
defin
one
differ
amino
acid
sequenc
shown
figur
million
sequenc
appear
ng
result
million
sequenc
appear
twice
million
sequenc
appear
time
frequent
repeat
clone
appear
time
ng
result
percentag
differ
type
vnar
plot
pie
chart
figur
base
number
extra
cystein
sequenc
type
six
cystein
total
type
ii
four
cystein
total
vnar
consid
classic
other
number
cystein
shown
figur
e
respect
repres
sequenc
type
shark
vnar
differ
number
cystein
randomli
pick
ng
data
shown
exampl
fig
fr
mark
base
stanfield
et
al
fennel
et
al
figur
sequenc
align
sequenc
imgt
databas
cdr
determin
shown
figur
part
sequenc
identifi
imgt
databas
vnar
may
multipl
cystein
residu
base
sequenc
ng
data
analyz
total
number
cystein
number
cystein
found
length
amino
acid
sequenc
variabl
due
high
variabl
length
defin
sequenc
conserv
framework
sequenc
tyrc
end
xxxgtxxtvn
total
cystein
vnar
sequenc
vari
fig
cystein
fig
length
vari
greatli
well
amino
acid
accord
ng
data
fig
separ
analysi
type
type
iiiii
vnar
show
type
vnar
shown
blue
line
total
cystein
type
iiiii
shown
red
line
fig
b
length
type
vnar
also
slightli
longer
compar
type
iiiii
fig
find
consist
publish
smallscal
sequenc
analysi
type
vnar
even
number
cystein
fig
high
variabl
length
cystein
number
crucial
divers
vnar
sinc
bind
divers
depend
structur
divers
amino
acid
sequenc
variat
analysi
show
sequenc
divers
mainli
contribut
minim
variat
fig
taken
togeth
design
pcrbase
method
establish
larg
shark
vnar
singledomain
antibodi
librari
size
librari
contain
type
shark
vnar
sequenc
well
mani
previous
undefin
type
evalu
librari
potenti
therapeut
develop
chose
varieti
human
tumor
biomark
viru
antigen
protein
select
target
includ
spike
protein
mer
sar
virus
pseudomona
exotoxin
four
round
pan
specif
binder
list
target
identifi
monoclon
phage
elisa
fig
binder
assign
follow
name
base
target
well
number
includ
one
binder
isol
antigen
except
mer
spike
protein
five
binder
isol
mer
spike
protein
sequenc
analysi
show
binder
type
ii
vnar
except
one
type
two
undefin
type
one
type
ii
binder
target
fragment
produc
e
coli
strain
singledomain
protein
nm
kd
bind
affin
antigen
measur
octet
kinet
assay
fig
c
affin
high
monomer
singledomain
solubl
protein
isol
shark
librari
without
immun
also
produc
type
binder
mer
type
ii
binder
mer
e
coli
protein
yield
vari
base
protein
sequenc
rel
low
yield
mg
l
e
coli
cultur
mer
binder
yield
mg
mer
yield
mg
singledomain
solubl
protein
ml
e
coli
cultur
nickelcharg
histrap
column
ge
healthcar
chicago
il
use
purifi
protein
polymyxin
b
lyse
bacteria
pellet
supernat
elut
profil
show
protein
elut
figur
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
sdspage
elut
peak
figur
e
show
later
peak
elut
higher
imidazol
concentr
puriti
target
solubl
vnar
mer
specif
bind
phage
pan
antigen
mer
spike
protein
figur
f
type
binder
mer
higher
signal
tsk
size
exclus
column
purif
type
ii
binder
solubl
singledomain
protein
show
protein
monomer
kda
protein
elut
one
peak
slightli
earlier
kda
control
protein
peak
fig
h
taken
togeth
binder
tumor
viral
antigen
includ
type
type
ii
singl
domain
contain
multipl
cystein
residu
select
librari
produc
function
singledomain
protein
e
coli
data
indic
new
shark
phage
librari
valuabl
platform
discoveri
vnar
binder
present
studi
develop
easel
method
construct
phage
display
librari
base
pcr
extens
assembl
follow
selflig
use
easel
method
success
construct
larg
phagedisplay
vnar
librari
size
six
nurs
shark
ng
analysi
data
show
phage
display
librari
larg
divers
final
use
panel
tumor
viral
antigen
protein
target
isol
shark
binder
antigen
screen
also
demonstr
type
type
ii
shark
vnar
binder
produc
e
coli
function
singledomain
protein
larg
nurs
shark
vnar
singledomain
phage
librari
describ
provid
attract
singledomain
antibodi
platform
drug
discoveri
studi
use
two
canon
cystein
locat
amino
acid
key
criterion
character
type
vnar
famili
total
vnar
fit
one
four
known
vnar
type
famili
identifi
total
vnar
classic
type
classic
type
ii
major
vnar
either
classic
type
type
ii
vnar
fit
four
classic
type
nonclass
vnar
variou
number
cystein
fig
futur
structur
function
analysi
binder
isol
librari
variou
antigen
need
understand
role
nonclass
vnar
therapeut
antibodi
discoveri
engin
key
success
isol
antibodi
phage
librari
use
select
variou
method
employ
make
antibodi
phage
display
librari
wide
use
method
consist
pcr
amplif
antibodi
fragment
follow
enzymat
digest
ligat
vector
method
time
consum
low
effici
ligat
transform
step
present
studi
develop
easel
method
construct
larg
shark
vnar
phage
librari
use
label
pcr
add
homologu
region
vnar
pool
overlap
extens
pcr
use
assembl
vnar
phagemid
dna
follow
selflig
whole
librari
dna
took
sever
week
make
shark
vnar
librari
convent
approach
would
requir
sever
month
protocol
significantli
shorten
time
requir
construct
larg
gene
librari
anoth
contemporari
method
use
gene
clone
gibson
assembl
method
base
enzymat
assembl
join
multipl
overlap
dna
fragment
singl
reaction
system
method
may
effici
gibson
assembl
gibson
assembl
requir
nick
dna
fragment
make
complementari
follow
anneal
togeth
dna
polymeras
use
fill
gap
dna
ligas
use
seal
gap
therefor
two
termini
ligat
ident
nucleotid
gibson
assembl
reaction
may
fail
due
complic
relat
total
repeat
densiti
direct
invers
palindrom
repeat
element
extrem
gc
content
secondari
structur
near
termini
sequenc
best
knowledg
report
use
gibson
assembl
develop
larg
phagedisplay
antibodi
librari
method
need
convent
dna
ligas
run
standard
ligat
h
two
end
dna
blunt
need
ident
bluntend
ligat
therefor
method
similar
tradit
bluntend
ligat
termin
part
dna
fragment
sequenc
vari
prepar
manuscript
laboratori
appli
easel
method
success
make
larg
camel
vhh
singledomain
phage
librari
taken
togeth
new
easel
librari
construct
method
robust
comprehens
quick
new
easel
method
also
maxim
sequenc
divers
repres
phage
librari
increas
select
highaffin
binder
previou
studi
produc
shark
phage
librari
divers
use
convent
clone
method
librari
divers
contain
known
four
type
vnar
singl
domain
major
sequenc
type
ii
type
vnar
shown
figur
interestingli
type
iv
vnar
sequenc
significantli
underrepres
shown
figur
shark
vnar
sequenc
ncbi
databas
mostli
deriv
bamboo
shark
dogfish
shark
wobbegong
shark
type
smaller
shark
percentag
vnar
type
significantli
differ
variou
speci
shark
interestingli
deep
sequenc
analysi
show
nurs
shark
vnar
sequenc
librari
categor
one
known
vnar
type
type
whether
novel
type
vnar
possess
uniqu
confirm
biophys
properti
analyz
structur
function
binder
cancer
viral
antigen
found
novel
type
vnar
futur
sinc
method
use
assembl
uniqu
vnar
sequenc
analysi
highli
accur
number
uniqu
sequenc
analyz
larg
use
unbias
method
analyz
sequenc
cystein
number
length
without
subdivid
four
known
vnar
type
signific
percentag
sequenc
classic
vnar
defin
known
four
type
analyz
data
sequenc
altogeth
would
provid
comprehens
pictur
sequenc
pattern
nurs
shark
without
fit
sequenc
defin
vnar
type
extra
cystein
type
type
ii
vnar
import
stabil
antigenbind
region
extra
disulfid
bond
form
cystein
essenti
form
divers
antigenbind
surfac
may
one
strategi
increas
antigenbind
region
divers
heavi
chainonli
antibodi
interestingli
sequenc
variat
mostli
lie
minim
variat
previou
literatur
suggest
sequenc
variabl
vivo
affin
matur
also
shown
somat
mutat
within
contribut
antigen
bind
howev
ng
result
present
studi
show
minim
sequenc
variabl
shark
librari
possibl
shark
use
studi
kept
captiv
long
time
therefor
much
sequenc
divers
anoth
major
type
heavi
chainonli
domain
antibodi
vhh
camel
also
highli
diversifi
length
vhh
much
longer
convent
vh
camel
igg
median
length
vhh
amino
acid
similar
shark
vnar
wherea
median
length
camel
vh
amino
acid
howev
comprehens
studi
cystein
number
locat
camel
vhh
sequenc
comparison
shark
vnar
hypothes
divers
larg
shark
librari
increas
significantli
random
sequenc
keep
highli
divers
exampl
eight
amino
acid
complet
random
diversifi
vnar
librari
furthermor
affin
matur
binder
figur
perform
random
summari
believ
shark
librari
suitabl
size
divers
antibodi
discoveri
potenti
use
larg
singledomain
antibodi
discoveri
platform
potenti
immunogen
shark
antibodi
could
concern
clinic
applic
concern
could
address
identifi
bcell
tcell
immunogen
epitop
silenc
specif
site
mutat
furthermor
durabl
immun
toler
highli
immunogen
protein
eg
bacteri
toxin
induc
nanoparticl
contain
rapamycin
vivo
conclus
built
larg
highli
divers
phagedisplay
vnar
librari
use
b
cell
isol
nurs
shark
provid
new
platform
discov
singledomain
antibodi
therapeut
diagnost
applic
easel
librari
construct
method
describ
may
applic
construct
larg
gene
express
librari
includ
antibodi
librari
deriv
speci
tcell
receptor
human
hepatocellular
carcinoma
cell
line
maintain
adher
monolay
cultur
dmem
medium
invitrogen
carlsbad
ca
supplement
fetal
bovin
serum
hyclon
logan
ut
lglutamin
penicillinstreptomycin
invitrogen
incub
cell
human
epitheli
carcinoma
cell
line
engin
laboratori
express
high
level
human
transfect
plasmid
encod
fulllength
stabli
transfect
cell
maintain
dmem
supplement
peptid
aa
synthes
recombin
extracellular
domain
sprotein
mer
sr
purchas
sino
biolog
beij
china
recombin
made
laboratori
accord
publish
method
recombin
gener
previous
publish
six
nurs
shark
three
male
three
femal
rang
ft
long
bled
ml
blood
phosphat
buffer
salin
pb
iuml
heparin
buffi
coat
collect
spun
resuspend
ml
trizol
rna
prepar
total
rna
isol
use
trizol
reagent
thermo
fisher
scientif
grand
island
ny
accord
manufactur
instruct
five
microgram
total
rna
reversetranscrib
cdna
total
volum
use
superscript
iii
firststrand
synthesi
system
thermo
fisher
scientif
accord
manufactur
instruct
one
forward
primer
two
revers
primer
synthes
pcr
amplifi
vnar
sequenc
cdna
product
forward
primer
ignarf
gctcgagtgaccaaacaccg
revers
primer
ggtggccggcctggccactattcacagtcacggcagtgccat
revers
primer
ggtggccggcctggccactattcacagtcacgacagtgccacc
primer
pair
use
amplifi
vnar
fragment
pcr
volum
contain
cdna
product
pcr
cycl
paramet
follow
initi
denatur
min
cycl
denatur
anneal
elong
use
primestar
clonetech
meantim
linear
vector
backbon
fragment
prepar
pcr
use
forward
primer
agtggccaggccggccacc
revers
primer
ggccgcctgggccacggta
five
nanogram
plasmid
use
templat
total
pcr
reaction
volum
primer
amplifi
vector
backbon
forward
agtggccaggccggccacc
revers
ggccgcctgggccacggta
pcr
cycl
paramet
follow
initi
denatur
min
cycl
denatur
anneal
elong
min
use
primestar
takara
shiga
japan
assembl
vnar
amplifi
vector
backbon
ng
vector
backbon
mix
ng
vnar
pcr
product
pcr
reaction
volum
overlap
extens
pcr
prime
primer
use
primestar
twenti
microgram
assembl
pcr
product
circular
intramolecular
selflig
ml
ligat
buffer
use
dna
ligas
new
england
biolab
ipswich
ligat
product
clean
remov
enzym
transform
electropor
compet
cell
lucigen
middleton
wi
make
librari
method
refer
easel
method
studi
ng
librari
gener
shark
vnar
insert
dna
digest
plasmid
librari
use
xhoi
msci
restrict
enzym
new
england
biolab
shark
vnar
librari
excis
vector
restrict
enzym
xhoi
msci
gel
purifi
insert
fragment
ligat
illumina
adaptor
sequenc
illumina
miseq
bp
pairedend
read
use
nebnext
ultra
ii
dna
librari
prepar
kit
kappa
hyper
prep
librari
prepar
kit
pairedend
read
merg
cover
full
length
insert
use
flash
merg
sequenc
read
analyz
custom
perl
script
dna
sequenc
orient
translat
protein
sequenc
sequenc
stop
codon
remov
analysi
also
requir
amino
acid
sequenc
start
rv
nterminu
end
xxxgtxxtvn
cterminu
consid
fulllength
vnar
select
criteria
almost
million
vnar
amino
acid
sequenc
experi
million
uniqu
vnar
sequenc
align
vnar
sequenc
anchor
constant
region
allow
region
variabl
length
amino
acid
calcul
variabl
accord
method
describ
wu
kabat
classifi
vnar
sequenc
differ
subtyp
base
residu
number
posit
type
type
iiiii
sequenc
also
analyz
separ
length
total
cystein
number
cystein
number
librari
bacteri
stock
inocul
l
media
contain
glucos
ampicillin
cultur
shake
rpm
cell
reach
midlog
phase
superinfect
perform
ad
helper
phage
pfuml
h
continu
growth
cell
pellet
resuspend
l
media
contain
ampicillin
kanamycin
incub
overnight
cell
centrifug
filter
membran
supernat
store
pan
phage
pan
protocol
describ
previous
briefli
well
maxisorp
elisa
plate
nuncthermo
fisher
scientif
rochest
ny
use
captur
variou
antigen
pb
buffer
overnight
coat
buffer
decant
plate
treat
block
buffer
bovin
serum
albumin
pb
room
temperatur
h
preblock
phage
supernat
typic
contain
cfu
block
buffer
ad
per
well
h
room
temperatur
allow
bind
four
wash
pb
contain
bound
phage
elut
mm
triethylamin
four
round
pan
singl
coloni
pick
identifi
use
phage
elisa
antigen
protein
use
coat
well
plate
pb
buffer
overnight
irrelev
antigen
use
bsa
pb
plate
block
bsa
pb
buffer
preblock
phage
supernat
typic
cfu
ad
plate
bind
detect
hrp
conjug
mous
antibodi
ge
healthcar
life
scienc
pittsburg
pa
cutoff
valu
posit
binder
set
higher
signal
antigen
bind
compar
background
nois
phagemid
contain
vnar
binder
transform
e
coli
cell
form
coloni
pool
cultur
l
media
contain
glucos
ampicillin
reach
cultur
media
replac
media
contain
mm
iptg
sigma
ampicillin
shook
overnight
solubl
protein
product
bacteria
pellet
spun
lyse
polymyxin
b
sigma
h
releas
solubl
protein
supernat
harvest
lysi
purifi
use
histrap
column
ge
healthcar
use
akta
shark
singledomain
solubl
protein
buffer
exchang
pb
buffer
purif
bind
kinet
measur
fortebio
octet
locat
biophys
core
nation
heart
lung
blood
institut
dilut
assay
buffer
pb
supplement
wv
bsa
octet
program
follow
min
presoak
baselin
establish
antigen
load
baselin
reestablish
antigen
load
associ
min
dissoci
total
use
load
ninta
biosensor
serial
dilut
antigen
protein
use
bind
assay
bind
kinet
calcul
fortebio
octet
softwar
statist
analys
conduct
use
graphpad
prism
graphpad
softwar
inc
la
jolla
ca
differ
group
analyz
use
twotail
student
ttest
mean
nation
cancer
institut
center
cancer
research
flex
program
technolog
develop
award
mh
intramur
research
program
nation
institut
health
nation
cancer
institut
center
cancer
research
bc
zia
bc
mh
nation
cancer
institut
nation
institut
health
contract
xw
